Medical/Pharmaceuticals
Fapon 2nd COVID-19 Donation, 100 Million Anti-SARS-CoV-2 Fully Human RBD IgM & IgG QC Test Materials
DONGGUAN, China, Aug. 10, 2020 /PRNewswire/ -- Fapon Biotech Inc
2020-08-10 20:00
1903
China Biologic Products to Report Second Quarter 2020 Financial Results
BEIJING, Aug. 10, 2020 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO) ("China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company inChina, today announced that the Company plans to release its second quarter 2020 financial results ...
2020-08-10 20:00
8870
miR Scientific Announces Validation of its Urine Based, Non-Invasive Prostate Cancer Test Published in the Journal of Urology
- Validated Data Reinforces Capability to Molecularly Detect and Characterize Prostate Cancer with Concurrent Sensitivity and Specificity of Over 91% - Data Support Integration of Sentinel Prostate Test™ in Patient Care Settings and Decision-Making - Adoption Based on Published Data Indicates Hi...
2020-08-10 19:30
3354
First patient in treatment in RhoVac's clinical phase IIb study in the USA
STOCKHOLM, Aug. 10, 2020 /PRNewswire/ -- The first patient in the USA is included in RhoVac's clinical phase IIb study, called BRaVac. The first US clinic to include a patient in the study was Carolina Urologic Research Center. BraVac is a randomized, placebo controlled and double-blind study, wi...
2020-08-10 16:47
1967
AVATAMED Raises US$1 Million in Seed Funding
SINGAPORE, Aug. 10, 2020 /PRNewswire/ -- AVATAMED, a precision medicine company based inSingapore, announced the completion of its Seed round funding of US$1 million, led by Future Leading Bio Funds, along with other investors. Professor Pierce Chow, Senior Consultant at National Cancer Centre Si...
2020-08-10 15:27
3168
Viva Biotech and Langhua Pharmaceutical Reached the Strategic Acquisition Agreement, Accelerating the Escalation of the Service Chain of Innovative Drug Industry
SHANGHAI, Aug. 10, 2020 /PRNewswire/ -- On August 9th, 2020, Viva Biotech ( Shanghai) Co., Ltd. (hereinafter referred to as "Viva Biotech" or "The Company") entered into the Share Purchase Agreement pursuant to which Viva Biotech agreed to acquire and the Vendors agreed to collectively sell 80% of...
2020-08-10 08:00
4025
Innovent and Lilly Release Clinical Trial Results of Sintilimab in Combination with ALIMTA® (Pemetrexed) and Platinum Chemotherapy as First-Line Treatment for Nonsquamous NSCLC in an Oral Presentation at IASLC WCLC 2020 Virtual Presidential Symposium
SUZHOU, China, Aug. 8, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, metabolic, autoimmune and other major diseases, today anno...
2020-08-08 21:00
17122
First hospitals in U.S. implant next-generation cardiac device to reduce risk of stroke
Texas Cardiac Arrhythmia Institute at St. David's Medical Center, Los Robles Health System perform near simultaneous implantation ofWATCHMAN FLX™ Left Atrial Appendage Closure (LAAC) AUSTIN, Texas, Aug. 8, 2020 /PRNewswire/ -- On Aug. 5, 2020, physicians at the Texas Cardiac Arrhythmia Institute ...
2020-08-08 10:08
4987
First liquid biopsy to receive FDA Approval for comprehensive tumor profiling across all solid cancers, Guardant Health's Guardant360® CDx, gains credibility among oncologists in Asia, Middle East and Africa.
SINGAPORE, Aug. 8, 2020 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has approved Guardant Health's liquid biopsy, Guardant360® CDx, for tumor mutation profiling in patients across all solid cancers. For Guardant Health Asia, Middle East and Africa (AMEA), this FDA approval r...
2020-08-08 03:21
5759
BD Announces Voluntary Recall of ChloraPrep™ 3 mL Applicator in Specific U.S. Territories, Countries and Regions
FRANKLIN LAKES, New Jersey, Aug. 7, 2020 /PRNewswire/ -- BD (Becton, Dickinson and Company), a leading global medical technology company,announced a voluntary recall onJune 23, 2020 for specified catalog numbers of the ChloraPrep™ 3 mL applicator due to possible fungal contamination, which only a...
2020-08-07 18:59
3691
Co-Diagnostics, Inc. Logix Smart™ COVID-19 Test Authorized for Use in Australia
SALT LAKE CITY, Aug. 7, 2020 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) , a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, announced today thatAustralia has been added to the list of countries that have authorized the Logix Smart™ C...
2020-08-07 18:30
9129
Olympus announces acquisition of Arc Medical Design Limited from Norgine B.V.
TOKYO, Aug. 7, 2020 /PRNewswire/ -- Olympus Corporation today announced it has signed a definitive agreement to acquire Arc Medical Design Limited (Arc Medical Design), a subsidiary of Norgine B.V. The acquisition underscores Olympus' commitment to expanding its offering in gastrointestinal thera...
2020-08-07 14:00
3584
US FDA Grants Rare Pediatric Disease Designation (RPDD) to Paxalisib for DIPG
SYDNEY, Aug. 7, 2020 /PRNewswire/ -- Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to announce that the United States Food and Drug Administration (FDA) has awarded Rare Pediatric Disease Designation (RPDD) to Kazia's paxalis...
2020-08-07 08:30
14078
CMAB Appoints Ms. Maggie Chen as Chief Financial Officer
SUZHOU, China, Aug. 6, 2020 /PRNewswire/ -- CMAB Biopharma (Suzhou) Inc. ("CMAB"), a dedicated biologics contract manufacturing and development organization (CDMO), today announced the appointment of Ms.Maggie Chen as the chief financial officer. Ms. Chen will lay a solid foundation for the long-...
2020-08-07 08:00
4612
Covistat, Biopharmaceutical Company Developing Low-Cost COVID-19 Treatment, Acquires IP From World Leader in Respiratory Disease Medicine
Technology, expertise from UK's Mucokinetica to accelerate repurposing of generic remedy nafamostat for COVID-19 oral, inhalation therapy SAN DIEGO, Aug. 7, 2020 /PRNewswire/ -- A biopharmaceutical company repurposing nafamostat, a generic remedy for pancreatitis and acute kidney injury, is one ...
2020-08-07 01:30
3986
Dietary cholesterol and phytosterols contribute directly to heart disease
Genetic variability in cholesterol and phytosterol absorption affects cardiovascular disease risk REYKJAVIK, Iceland, Aug. 7, 2020 /PRNewswire/ -- Scientists at deCODE genetics , a subsidiary of Amgen, and their collaborators fromthe Icelandic healthcare system, University of Iceland, the Copenha...
2020-08-07 01:21
5637
ImmVira and Shanghai Pharma Announce Clinical Collaboration and License Agreement for Commercialization of Novel Intratumoral Oncolytic Virus Immunotherapies
SHENZHEN and SHANGHAI, August 6, 2020 /PRNewswire/ -- ImmVira Group Company and Shanghai Pharmaceuticals Holding Co., Ltd today announced a clinical collaboration and exclusive license agreement for ImmVira's MVR-T3011 intratumoral oncolytic virus program for the commercialization of novel immun...
2020-08-06 23:49
9546
The 23rd TDO® Software and 2nd GentleWave® User Meeting Moving to an All Virtual Experience
LAGUNA HILLS, California, Aug. 6, 2020 /PRNewswire/ -- Sonendo, Inc., a leading dental technology company, developer of theGentleWave System and the parent company of TDO Software Inc., the leading endodontic practice management software developer, announced today that its Annual TDO and GentleWa...
2020-08-06 20:32
3652
I-Mab to Report Financial Results for the Six Months Ended June 30, 2020 and Provide Corporate Update on August 31, 2020
SHANGHAI and GAITHERSBURG, Md., Aug. 6, 2020 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced that it will report financial results for the six months ...
2020-08-06 20:30
14828
Caprion-HistoGeneX and Viroclinics-DDL announce a strategic partnership to offer integrated, complementary services to advance infectious disease research and COVID-19 therapeutic development
Caprion-HistoGeneX, a specialized CRO providing immunology, proteomics, histopathology and genomics services, and Viroclinics-DDL, a provider of preclinical and clinical trial services for vaccine, antiviral, and diagnostic development, are pleased to announce a new partnership that will offer gl...
2020-08-06 20:10
2819
Week's Top Stories
Most Reposted
Going Global: DCITS Embarks on International Expansion at Singapore Fintech Festival
[Picked up by 313 media titles]
2024-11-12 09:00
DKSH Healthcare and Euris Unveil CRM & MCE Platform "ConnectPlus" to Revolutionize APAC Healthcare Distribution
[Picked up by 293 media titles]
2024-11-13 09:00
Sobot Introduces its All-in-One Solution at GITEX Global 2024
[Picked up by 291 media titles]
2024-11-12 11:00
Ubiqconn Technology to Showcase Latest Marine Solutions at the 2024 International WorkBoat Show in New Orleans
[Picked up by 289 media titles]
2024-11-11 21:00
DND International Eye Hospital: Pioneering SMILE Pro Surgery & Leading the Trend of Refractive Surgery Tourism in Vietnam
[Picked up by 279 media titles]
2024-11-08 20:11
Most Read
Ubiqconn Technology to Showcase Latest Marine Solutions at the 2024 International WorkBoat Show in New Orleans
2024-11-11 21:00
5634
DND International Eye Hospital: Pioneering SMILE Pro Surgery & Leading the Trend of Refractive Surgery Tourism in Vietnam
2024-11-08 20:11
5568
HOIANA RESORT & GOLF LAUNCHES PREMIUM HOIANA PICKLEBALL COURT
2024-11-08 00:18
5520
Going Global: DCITS Embarks on International Expansion at Singapore Fintech Festival
2024-11-12 09:00
5403